Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
13.31
+0.14 (1.06%)
Sep 14, 2026, 3:04 PM CST
SHE:300181 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 648.24 | 680.88 | 804.67 | 931.98 | 1,082 | 232.3 |
Trading Asset Securities | - | - | - | 151 | 10.83 | 65.52 |
Cash & Short-Term Investments | 648.24 | 680.88 | 804.67 | 1,083 | 1,093 | 297.82 |
Cash Growth | -11.36% | -15.38% | -25.70% | -0.91% | 266.97% | -5.39% |
Accounts Receivable | 1,247 | 1,139 | 783.33 | 532.42 | 510.07 | 337.33 |
Other Receivables | 14.52 | 18.01 | 18.18 | 9.02 | 24.42 | 26.77 |
Receivables | 1,261 | 1,157 | 801.52 | 541.44 | 534.5 | 364.1 |
Inventory | 570.56 | 531.81 | 523.75 | 426.52 | 318.83 | 273.59 |
Prepaid Expenses | - | 3.97 | 0 | - | 7.87 | - |
Other Current Assets | 43.35 | 17.24 | 47.51 | 5.53 | 5.45 | 6.16 |
Total Current Assets | 2,523 | 2,391 | 2,177 | 2,056 | 1,960 | 941.67 |
Property, Plant & Equipment | 1,480 | 1,427 | 1,220 | 1,060 | 972.41 | 806.32 |
Long-Term Investments | 382.27 | 411.57 | 254.64 | 179.7 | 392.36 | 650.67 |
Goodwill | 321.37 | 130.32 | 130.32 | 130.32 | 130.32 | 130.32 |
Other Intangible Assets | 275.71 | 82.42 | 75.08 | 71.27 | 63.04 | 64.89 |
Long-Term Deferred Tax Assets | 32.71 | 31.79 | 30.4 | 25.5 | 25.14 | 15.51 |
Long-Term Deferred Charges | 60.53 | 50.09 | 35.58 | 25.49 | 25.42 | 25.6 |
Other Long-Term Assets | 122.53 | 186.72 | 68.91 | 78.07 | 74.76 | 113.55 |
Total Assets | 5,198 | 4,712 | 3,992 | 3,627 | 3,643 | 2,749 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 537.1 | 425.26 | 482.41 | 433.85 | 468.88 | 296.77 |
Accrued Expenses | 25.53 | 127.25 | 86.53 | 82.24 | 78.32 | 62.33 |
Short-Term Debt | 713.3 | 660.09 | 377.31 | 193.06 | 138.16 | 178.2 |
Current Portion of Long-Term Debt | 4.14 | - | - | 10.01 | 0.01 | - |
Current Portion of Leases | - | 3.19 | 3.35 | 2.49 | 2.83 | 4.21 |
Current Income Taxes Payable | 127.52 | 69.26 | 52.54 | 32.65 | 26.59 | 16.46 |
Current Unearned Revenue | 11.1 | 5.26 | 14.45 | 2.23 | 14.14 | 3.06 |
Other Current Liabilities | 234.84 | 48.64 | 39.46 | 38.28 | 26 | 23.55 |
Total Current Liabilities | 1,654 | 1,339 | 1,056 | 794.83 | 754.94 | 584.58 |
Long-Term Debt | 46.66 | 11.66 | 30.66 | - | 10 | - |
Long-Term Leases | 17.59 | 17.07 | 18.27 | 16.69 | 22.13 | 24.27 |
Long-Term Unearned Revenue | 28.07 | 27.65 | 26.5 | 19.9 | 19.76 | 22.37 |
Long-Term Deferred Tax Liabilities | 67.77 | 75 | 41.03 | 21.68 | 76.24 | 134.1 |
Total Liabilities | 1,814 | 1,470 | 1,173 | 853.09 | 883.07 | 765.31 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 701.39 | 701.39 | 701.39 | 701.39 | 701.39 | 608.62 |
Additional Paid-In Capital | 1,145 | 1,142 | 1,135 | 1,135 | 1,135 | 340.48 |
Retained Earnings | 1,389 | 1,257 | 1,041 | 849.32 | 676.8 | 525.52 |
Treasury Stock | -81.45 | -111.88 | -203.97 | - | - | - |
Comprehensive Income & Other | 171.39 | 191.62 | 94.63 | 42.66 | 190.19 | 369.44 |
Total Common Equity | 3,326 | 3,180 | 2,769 | 2,729 | 2,704 | 1,844 |
Minority Interest | 58.75 | 61.25 | 50.56 | 45.2 | 56.18 | 139.15 |
Shareholders' Equity | 3,385 | 3,241 | 2,819 | 2,774 | 2,760 | 1,983 |
Total Liabilities & Equity | 5,198 | 4,712 | 3,992 | 3,627 | 3,643 | 2,749 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 781.69 | 692.01 | 429.59 | 222.25 | 173.13 | 206.67 |
Net Cash (Debt) | -133.45 | -11.13 | 375.08 | 860.73 | 919.77 | 91.15 |
Net Cash Growth | - | - | -56.42% | -6.42% | 909.09% | - |
Net Cash Per Share | -0.19 | -0.02 | 0.54 | 1.24 | 1.52 | 0.15 |
Filing Date Shares Outstanding | 662.07 | 693.22 | 692.47 | 701.39 | 701.39 | 608.62 |
Total Common Shares Outstanding | 662.07 | 693.22 | 686.49 | 701.39 | 701.39 | 608.62 |
Working Capital | 869.87 | 1,052 | 1,121 | 1,262 | 1,205 | 357.1 |
Book Value Per Share | 5.02 | 4.59 | 4.03 | 3.89 | 3.85 | 3.03 |
Tangible Book Value | 2,729 | 2,967 | 2,563 | 2,527 | 2,510 | 1,649 |
Tangible Book Value Per Share | 4.12 | 4.28 | 3.73 | 3.60 | 3.58 | 2.71 |
Buildings | - | 1,223 | 1,014 | 962.71 | 832.63 | 678.11 |
Machinery | - | 580.69 | 529.12 | 467.55 | 432.59 | 412.82 |
Construction In Progress | - | 173.97 | 161.43 | 61.14 | 78.06 | 40.29 |